The machine-washable wound/bandage protector is available in denim blue, in five different sizes.
Pads, sold separately, can be added to pockets in the Head Cover for additional protection. Alternatively, the pockets can be used to hold a dog’s ear to prevent wound fluids and ointments from sticking to the fur.
The company has also announced the launch of the new Medical PetS Boot, a waterproof paw protector which, unlike the alternatives, comes in a variety of sizes and is firmly held in place with both velcro straps and a drawstring.
For more information, visit: https://www.jakmarketing.co.uk or ring 01347 878697
The company has identified that inconsistencies in the cleaning process have led to low levels of a previous product being carried over into the Stresnil batch no PP1466, EXPIRY: 30-09-2019.
For more information about the recall, contact Matthew Edwards: elanco_orders@lilly.com or telephone: 01256 779519.
According to the AHT, glaucoma affects more than a thousand dogs across the UK. Now Border Collie breeders will be able to use this test to reduce the risk of producing glaucoma-affected puppies, whilst maintaining genetic diversity.
The work that resulted in the new test began at the Roslin Institute in Edinburgh, where scientists found a variant in a gene called OLFML3 reported to be associated with severe goniodysgenesis and glaucoma in Border Collies.
On reading this research, the AHT’s canine genetics team, which has an ongoing research programme looking at canine glaucoma, began to look at how a DNA test could be offered based on the mutation.
Hattie Wright, Vets4Pets Research Assistant at the AHT, genotyped a large cohort of Border Collies for the mutation, in order to obtain an accurate measure of the association between the mutation and goniodysgenesis and glaucoma in the Border Collie. These dogs all had their eyes examined, and their DNA collected, by veterinary ophthalmologist James Oliver.
The charity’s findings from this validation process replicated the findings of the Roslin Institute, so the AHT has been able to develop and launch a DNA test based on the reported OLFML3 mutation.
Dr Cathryn Mellersh, Head of Canine Genetics at the Animal Health Trust, said: "We’re delighted to offer this test to Border Collie breeders and hope in time, through its use, we can lessen the prevalence of this disease in this lovely breed.
"Our research has found that the mutation is only associated with glaucoma in Border Collies, so we will publish our data at the earliest opportunity, in the hope that other commercial DNA testing providers will not be tempted to make the DNA test available to breeds other than the Border Collie."
For more information, visit: www.ahtdnatesting.co.uk
Insistor, which contains methadone hydrochloride, is now available in the UK in a 10ml bottle for use in dogs and cats, POM-V.
Chanelle says Insistor can also be used for analgesia in animals experiencing post-operative pain or pain caused by trauma.
Chanelle’s Head of Sales and Marketing, Killian Gaffney, said: "Insistor joins Chanelle’s extensive anaesthetic, analgesic and sedative range. Insistor (methadone hydrochloride), Butador (butorphanol) and Bupaq (buprenorphone) complete the 360° Opiod suite of products from Chanelle.
"We are pleased to add Insistor to our portfolio of products, which builds the offering to veterinary surgeons of anaesthetic products."
The popular novels, which were written by real life Yorkshire vet Alf Wight, depicted Herriot - and others like him - as working all hours, doing favours for clients free of charge and being paid in cake, all with scarcely a mention of how he made ends meet.
This misguided image still informs expectations of the profession today, they say.
Henry Tremaine, a specialist in equine surgery and dentistry, said: "The nostalgic thing is of this romantic life driving around in an old car being appreciated by the clients - but actually the reality is working very long hours in stressful conditions with poor reward, being poorly equipped, and with unappreciative clients.
"That’s being consigned to history - gradually - but I think the public still cling onto the notion that that’s what a vet’s life is."
His comments echo those of BSAVA President, Sue Patterson, who earlier this year blamed James Herriot for the assumption among some clients that vets' love of animals would make them prepared to work for nothing: "I think James Herriot is to blame because we’re all supposed to love animals and work for nothing, but we all run businesses."
At the BEVA Congress earlier this month, equine vet and congress speaker, Ben Mayes, who graduated in 1992, also criticised the Herriot legacy for making it harder for vets to achieve a good work-life balance: "We’ve been left in that Herriot mentality, and it was a nightmare."
This week's edition of the Vet Record has six case studies of veterinary surgeons who have pursued careers through non traditional routes, including Peter Harlech Jones, Daniella Dos Santos, (pictured right), and Enrique Vega.
Daniella Dos Santos said: "James Herriot continues to inspire vets and future vets, and we know from our own research that he along with other vets in literature is still very popular across the profession.
"At the same time, the profession is very different to what was depicted in the age of Herriot and it continues to undergo significant change. We need to make sure that there is a diverse range of role models in place that reflect modern demographics and modern ways of working while continuing to inspire future generations of vets."
Adele Waters, Vet Record editor, added: "James Herriot may be a popular cultural figure, but he is 70 years out of date and we should retire him gracefully. With 60 per cent of UK vets being female, Herriot is no longer representative of the modern working vet, and today we should really be talking about Jane Herriot instead."
ECM, a French manufacturer of ultrasound devices, has launched Exago, a new mobile veterinary ultrasound device which the company says is particularly suited for use with horses and pets.
ECM says the main features of the new device are:
For more information, visit: http://www.agroscan.com/
Lead surgeon at Roundhouse, Ross Allan (pictured right), an RCVS Advanced Practitioner in Small Animal Surgery, said: "We know many practitioners and clients have been frustrated by the difficulties in availability of TPLO in Scotland and we wanted to change that.
"As with our other Roundhouse Referral offerings, we have done away with long waiting lists, unpredictable pricing, and challenges in clinical continuity. We know that in doing so we will revolutionise access to this service and the experience of its users.
"Our TPLO service offers excellent value and quality – we have invested heavily in the very best DePuy Synthes TPLO plates and implants and, together with our hospital status, standards and track record, we are offering a premier TPLO service in Scotland: a TPLO with a recovery that is as reliable and predictable as our Fixed Price!"
The fixed prices for a TPLO are £3000 for dogs under 40kg and £3100 for dogs over 40kg.
The price includes the consultation, diagnostic X-rays/assessment, pre-surgical blood samples, hospitalisation, anaesthesia, surgery (including implants), follow up consultation and follow up X-rays.
Ross added: "We don’t expect anything to go wrong, but should we need to revise our surgery we would do so at no additional cost to the client – that’s our Fixed-Price Fix!"
To make an enquiry, or refer a patient for a Fixed Price Fix TPLO contact Roundhouse Referrals at 0141 649 1316 www.rhr.vet
Merck has announced that its animal health division, formerly known as Intervet/Schering-Plough, has changed its name to MSD Animal Health in countries outside the United States and Canada from today.
Intervet/Schering Plough will now be known as Merck Animal Health in the United States and Canada.
Raul Kohan, President of Merck Animal Health said: "The name change reflects Merck's commitment to animal health and its complementary role to the overall business. We are unwavering in our commitment to veterinarians, producers, pet owners and society as a whole. We aim to generate additional value and sustained growth by continuing to provide integrated solutions with innovative animal health products and services to meet the evolving needs of our customers."
Mr. Kohan continued: "With the scientific and business backing of Merck, Merck Animal Health possesses the necessary mix of resources to enhance our position as an industry leader."
Merck says it values the diversification that Merck Animal Health brings to its portfolio, and sees growth opportunities in the business that can be leveraged across both animal and human health. The company intends to capitalize on Merck Animal Health's broad and innovative portfolio going forward, and to develop the unit into a best-in-class global animal health leader.
The name change follows the joint announcement on March 22, 2011 by Merck and sanofi-aventis that ended plans to form a new animal health joint venture. Both companies mutually decided to discontinue their agreement primarily because of the increasing complexity of implementing the proposed transaction.
RCVS President Neil Smith has issued a statement in response to the petition by Devon vet Jo Dyer which called for the removal of mandatory house visits from the Code of Professional Conduct and received just shy of 1300 signatures over the past 48 hours.
The statement reads:
"I am delighted to see that so many veterinary surgeons are taking seriously our call for views and evidence on all aspects of the provision of 24-hour emergency cover, including those who have signed up to veterinary surgeon Jo Dyer's petition calling for the removal of 'mandatory house visits' from the Code of Professional Conduct.
"However, I am concerned that the petition is working on a misunderstanding. Veterinary surgeons are not mandated to attend away from the practice just because an owner has requested a visit. It is a professional decision based on a range of factors.
"In fact, paragraph 3.13 of the Supporting Guidance to the Code of Professional Conduct states 'Clients may request attendance on a sick or injured animal away from the practice premises and, in some circumstances, it may be desirable to do so. On rare occasions, it may be necessary on clinical or welfare grounds. The decision to attend away from the practice is for the veterinary surgeon, having carefully balanced the needs of the animal against the safety implications of making the visit; a veterinary surgeon is not expected to risk 'life or limb', or that of anyone else, to provide the service.'
"I appreciate that recent disciplinary hearings, especially that of Mr Chikosi, have increased concerns in the profession that vets will be disciplined for not turning out to every single request for a home visit. This is not the case. In order for someone to be taken to a disciplinary hearing for refusing to attend away from the practice, first there needs to be a complaint, and second, the Preliminary Investigation Committee needs to be convinced that the veterinary surgeon could not justify their decision. Such cases are rare. In fact, last year, only 3% of the complaints we received were about 24-hour cover, and not all of those related to home visits.
"Having said this, the number of signatures received on Jo Dyer's petition, and the comments of the signatories, will be fed into the material reviewed by the Standards Committee, alongside formal responses to our call for evidence, and views gathered from animal-owner research. Clearly if so many veterinary surgeons believe that house visits are mandatory in all circumstances, the wording of our guidance needs to be reviewed, at the very least.
"It is likely that any recommendations for change in our 24/7 policy would go to the June meeting of Council, although this timetable is subject to change, depending on the nature of the report from the Standards Committee."
The RCVS Disciplinary Committee has dismissed a case against a Southampton veterinary surgeon after finding him not guilty of serious professional misconduct, saying at all times that he acted in the best interests of a dog under his care.
At the start of the five-day hearing, the charges against Edward Gillams MRCVS were that, whilst in practice at Vets Now in Southampton in 2011, he discharged a dog that he knew or ought to have known was in no fit state to be discharged, and, at the same time, failed to provide adequate advice and information to the dog's owners, particularly with regard to an alternative plan to discharge and treatment options.
The dog, an Italian Spinone called Zola, had first been taken to the Vets4Pets veterinary clinic in Southampton at 4.30pm on 2 November 2011, where gastric torsion was diagnosed. During a subsequent gastrotomy, 3kg of sausages and plastic wrappings were removed. Zola was discharged three days later, with a guarded prognosis from the operating veterinary surgeon. Zola's condition deteriorated that same evening, so his owners called the Vets4Pets practice and were referred to their out-of-hours provider, Vets Now, where Mr Gillams was on duty. On admitting Zola, the only information available to Mr Gillams was what the dog's owners were able to tell him.
The Committee heard differing witness accounts from the dog's owners and from Mr Gillams regarding what tests and examinations were to be performed, and what advice and options were suggested. Ultimately, Zola was hospitalised overnight (despite some reluctance for this from one of his owners), given pain relief and antibiotics and placed on a drip; he was then to be collected by his owners first thing for transfer back to Vets4Pets. The next morning, Zola was described as 'sternally recumbent but responsive', holding his head up but not moving and not making any attempt to get up. Mr Gillams carried Zola to his owner's car for transport back to the Vets4Pets practice. He considered that he had discharged his duty to provide advice, as this was given the night before and in the circumstances prevailing in the morning there was no obligation to repeat this. Zola died on the journey between the two practices.
Before reaching a decision, the Committee considered, in detail, the expert evidence of witnesses for both the College and Mr Gillams, which provided some conflicting views on Mr Gillams' actions. It also referred to the RCVS guidance available to Mr Gillams at the time through the RCVS Guide to Professional Conduct 2010.
The Committee noted that both experts agreed that Mr Gillams could not have known Zola was about to die when he discharged him and that it was a difficult decision for Mr Gillams to make, but expressed differing views about the fitness of the dog to be discharged and whether it was in its best interests to be discharged. The Committee rejected the contention that Mr Gillams ought to have known that Zola was not fit to be discharged, and instead considered appropriate his decision to discharge him into the care of his original veterinary surgeon. It felt that continuity of care would actually be better maintained in this manner, rather than a third veterinary surgeon taking over the case.
Regarding provision of adequate advice, the Committee accepted Mr Gillams' evidence that he was frustrated that the owners refused him permission to undertake the diagnostic work necessary to treat Zola effectively, and that he had no other clinical information to work with.
Chairing and speaking on behalf of the Disciplinary Committee, its Vice-Chairman, Ms Judith Webb, said: "The Committee expresses its sincere condolences to [the owners] for the loss of their much loved family pet Zola and recognises that this loss caused the family great distress."
Ms Webb added: "The Committee accepts that [Mr Gillams] discharged his obligations to Zola and to [his owners] in a manner wholly consistent with the standards of a competent veterinary surgeon in difficult circumstances. He leaves with no stain on his character or professional ability."
The full detail of the Committee's decision is available on the RCVS website (www.rcvs.org.uk/disciplinary).
Dermot Costello, a Shropshire practitioner, has been suspended by the RCVS Disciplinary Committee for 10 weeks after he admitted being dishonest with a client and falsifying records about the treatment of her dog.
Mr Costello faced four charges against him:
At the outset of the hearing, Mr Costelloe, a partner at a veterinary practice in Market Drayton, Shropshire, admitted all heads of charge against him.
Scruffy had been brought to Mr Costelloe for a consultation on 27 October 2014. He carried out a physical examination and arranged for radiographs and routine blood tests while also prescribing anti-inflammatory tablets for spondylosis. Scruffy was brought back to the practice on 30 October 2014 following the deterioration of her condition. Further assessment took place and an abdominal scan was arranged for the next day. She stayed at the practice overnight, but died at some point during the night of 30 to 31 October 2014.
A telephone call between Mrs Green and Mr Costelloe took place shortly after 8am on 31 October during which he told her that "they had struggled with Scruffy all night" and that, as they were speaking, Scruffy was on oxygen and struggling to breathe.
After Mrs Green said she wanted to come to the practice to be with her dog, Mr Costelloe told her to wait and that he would call her back in two minutes. He did so and told her Scruffy had died five minutes ago, when in fact she had died at some point between 11pm on 30 October and 8am on 31 October.
Mr Costelloe continued the deception at meetings with Mrs Green on 31 October and 19 November 2014 and she was given the falsified clinical records on 4 December 2014. Another meeting took place on 14 January 2015 where Mr Costelloe finally admitted his deception to her. This resulted in Mrs Green submitting a formal complaint to the RCVS on 23 February 2015. He admitted his deception to the College in writing on 4 August 2015.
The Committee decided that all four heads of charge amounted to disgraceful conduct in a professional respect as his actions contravened several sections of the Code of Professional Conduct for Veterinary Surgeons in relation to being open and honest with clients; keeping clear, accurate and detailed clinical records; and not engaging in any actions or behaviour that would likely bring the profession into disrepute or undermine public confidence in the profession.
The Committee noted that, in his statement, Mr Costelloe gave a number of reasons for his conduct, including concern over Mrs Green’s reaction to the death of her dog and concern for the young vet who was on duty when Scruffy died. However, the Committee considered that the need to be open and honest with his clients should have been put above the needs of his practice.
In considering its sanction against Mr Costelloe, the Committee heard mitigating evidence from four character witnesses called on his behalf, as well as a number of written testimonials, and also had regard to his evident remorse, shame and insight into his behaviour.
However, it also considered a number of aggravating factors, including the fact that the misconduct had premeditated elements, was sustained over a period of weeks, and constituted a clear breach of client trust.
The Committee decided that the most appropriate sanction was to suspend Mr Costelloe from the Register for a period of 10 weeks. Chitra Karve, chairing the Committee and speaking on its behalf, said: "It [the Committee] concluded that this was the appropriate and proportionate sanction in this case. The Committee took the view that the likelihood of repetition of dishonest conduct was very low. It had found no ‘attitude of dishonesty’ in the respondent. There were no risks to the welfare or health of animals. The respondent was a good veterinary surgeon and he had shown considerable insight regarding his dishonesty, for example, by actively seeking out Ms Green to tell her the truth.
"The Committee does not condone what the respondent has done. It considers that the public interest requires that there has to be confidence that veterinary surgeons do not fabricate accounts or documents, no matter what their intentions."
She added: "The Committee has therefore determined that suspension for a period of 10 weeks is proportionate in all the circumstances to mark the nature and gravity of the case and is sufficient to maintain public confidence in the profession and to uphold proper standards of conduct and behaviour, and directs the Registrar accordingly."
The Committee’s full findings and decision are available on the RCVS website (www.rcvs.org.uk/disciplinary).
In one of the finest pieces of investigative journalism since Watergate, the erstwhile-criminal-law-barrister-cum-tv-reporter Robert Rinder discovered that he could buy a wormer for his dog from some online retailer for half the price that he'd bought it at his veterinary practice.
Incensed by his discovery that things can cost less online, Mr Rinder then asked a handful of pet owners whether they could recall seeing a sign at their practice to advise them that they could buy things cheaper elsewhere.
None could. But then I'll bet if he asked whether they could remember a sign for the toilet, they'd have struggled.
Still, by now certain they'd found evidence that pet owners are being 'fleeced', Watchdog then rang 70 practices to ask for the price of some common drugs and then compared them to the prices being offered by online retailers.
Their research confirmed the awful truth. Some places really do charge more than others.
Honestly, who, in a million years, would have guessed?
BBC Watchdog (piece starts at 42:25).
The association has written a joint letter with the British Equine Veterinary Association and the Association of Veterinary Anaesthetists to the Veterinary Medicines Directorate asking for licence to be granted to specials manufacturers to produce isoflurane whilst the shortage persists, which Zoetis forecasts will be until March 2019.
In addition, the association's incoming Chair of the BSAVA Scientific Committee, Ian Self, an RCVS Specialist in Veterinary Anaesthesia and Analgesia has provided advice to support practitioners looking for alternative anaesthesia options, available here: https://www.bsava.com/News/ArticleID/2535/Isoflurane-supply.
The association has also made Chapter 14 of its online edition of the BSAVA Manual of Canine and Feline Anaesthesia and Analgesia 3rd edition free to access until the end of March 2019. The manual contains further information on alternative solutions such as TIVA (Total Intravenous Anaesthesia protocols) which some will be unfamiliar with.
The manual can be accessed here: https://www.bsavalibrary.com/content/chapter/10.22233/9781910443231.chap14
The chewable, prescription-only tablet contains sarolaner, which kills fleas and ticks; moxidectin, for the prevention of heartworm, lungworm disease and for the treatment of some intestinal worms; and pyrantel embonate, for the treatment of gastrointestinal nematodes (hookworms and roundworms).
Professor Tim Geary, BSc PhD, Professor Emeritus, Institute of Parasitology, McGill University, Canada, and Professor, School of Biological Sciences, Queen’s University, Belfast, a consultant to Zoetis, said: “Serious diseases that are preventable and of increasing prevalence threaten dogs in Canada and Europe. Simparica Trio today offers a better solution to preventing and controlling these parasites against the concern of their increasing prevalence."
Rob Kelly, President, International Operations at Zoetis said: "With Simparica Trio, we bring to market an advanced parasiticide solution, helping to deliver improved client satisfaction and patient protection.
"Thanks to its broad spectrum, Simparica Trio helps veterinarians and dog owners provide more complete parasite coverage with a single-monthly chewable tablet. The broad spectrum of Simparica Trio minimises the potential risk of parasite protection gaps."
Simparica Trio is indicated for dogs from at least eight weeks of age and 1.25 kg and will be available in six tablet strengths for dogs of all sizes.
For more information about Simparica Trio and full prescribing information, visit www.zoetis.com.
Vets Now has published a response to the RCVS DC ruling in which Munhuwepasi Chikosi, a locum working for the company, was struck off for delaying an emergency OOH home visit.
The response is available in full here: http://www.vets-now.com/news/?item=4191
Derbyshire surgeon Victoria Lilley BVSc CertSAM MRCVS has launched a petition calling on the RCVS to abandon its plans to remove Certificate and Diploma holders' post nominals from the RCVS Register at www.rcvs.org.uk.
Under the current plan, which followed a consultation in 2011 and a submission to Council in 2012, the College will only distinguish the new "Advanced Practitioners" and "RCVS Recognised Specialists" in the Register from some time after the autumn. Vets with old-style RCVS Certificates can apply for "Advanced Practitioner" status but must complete module A of the CertAVP or 100 hours of equivalent CPD and pay £50 to apply, plus £110 per year to maintain the status.
Victoria said: "I want to spread the word that this is happening, as I don't feel the RCVS has publicised it well enough. I did my certificate in practice, it was a lot of hard work and I feel that the RCVS removing my CertSAM post-nominals from the register undermines this. Whilst I acknowledge that I could apply for "Advanced Practitioner" status, I strongly feel that spending a large proportion of my CPD time and budget learning about ethics and public safety is not going to help me improve my small animal medicine knowledge or skills. I also don't feel that I should be penalised by having to pay to be an "Advanced Practitioner" when the Royal College should be supportive of vets who undertake further study. My biggest objection is to post-nominals being removed from the register, which I feel is very unfair."
Speaking at the RCVS's online Question Time on thewebinarvet.com, RCVS Treasurer and Vice-President-elect Dr Bradley Viner said: "To clarify the situation with the Register: the Register no longer goes out to members routinely as a printed document. It is now primarily online, and in line with other regulators such as the GMC, the only information that is in the official part of Register is whether that person is a Member or a Fellow of the Royal College of Veterinary Surgeons and their registrable qualifications, in other words the primary qualification they achieved which entitled them to become a Member or Fellow of the Royal College.
"But we are certainly not going to be inhibiting people from using their post-nominals freely. They can use any of the post-nominals that they have achieved as long as they are not misleading.
"But I think there is confusion between a qualification and a status. A qualification is something that you obtain and you've got for life, and of course the old style Certificate is one of those, the new RCVS CertAVP is another. A status is something that a qualification within our context might enable you to attain, but it is something that has to be maintained.
"So what is going to be happening, hopefully from autumn this year, is that in line with the recommendations of the Specialisation Working Party, [there will be] an extra tier. So there will be Practitioners, there will be Advanced Practitioners and there will be RCVS Recognised Specialists, and there will be lists of those available via the Royal College. An Advanced Practitioner will be somebody who has a relevant qualification in the area of their advanced practice, and that may well be an old-style Certificate, certainly the CertAVP but there are also other qualifications which can also be relevant and used for that purpose. But they also have to prove that they are working actively in that area of practice, and they have an advanced requirement for CPD.
"Now in the case of old style RCVS Certificate holders, that qualification will be in line with the qualification they require to be listed as an Advanced Practitioner, but within the first three years they will have to show that they have either done the RCVS A module which is part of the new RCVS Certificate, or have done work that is equivalent to that in various areas such as communications, teamworking and personal and professional development, because we think from a Royal College point of view that it is really important that those areas are included within the Advanced Practitioner Status."
To sign the petition, visit: http://www.change.org/en-GB/petitions/royal-college-of-veterinary-surgeons-keep-post-graduate-qualifications-on-the-rcvs-register?recruiter=89624244&utm_campaign=mailto_link&utm_medium=email&utm_source=share_petition
The BEVA has welcomed the news, whilst expressing its concern that the drug was suspended without consultation with the veterinary profession in the first place.
Jon Pycock, BEVA President said: "It remains a concern to BEVA that this mechanism was not put in place before the suspension of flunixin was imposed. Contrary to assertions by the VMD, wholesalers were unable to meet the demands of the veterinary profession and clinical use of this medicine was disrupted within 24 hours of the VMD’s initial announcement.
"We are surprised by the Regulator’s lack of awareness of availability in the supply chain and question why there was no consultation with the veterinary sector before the suspension was enacted. The VMD has been aware of this issue since March 2018 and it appears that no contingency was put in place to consider the animal welfare impact of this decision until it was too late."
BEVA Junior Vice President and Specialist in Equine Surgery Tim Mair continued: "Flunixin is a unique medicine in managing pain and sepsis in horses with colic. The VMD appeared to believe that this medicine could be substituted for other veterinary medicines and this is simply not the case. The release of stock from manufacturers is a short-term solution and, looking forward, we would like assurances that the VMD will fast track applications for the modification of product licenses to ensure that equine vets have continued access to these products."
Professor Kate White, Senior Vice President of the Association of Veterinary Anaesthetists added: "Provision of pain relief is essential to maintain animal welfare. The loss of these products would hinder the work of vets working with horses and donkeys and in zoos where they are first line drugs for the management of pain. Use of flunixin in these animals can be undertaken safely with no impact on human health."
Stock of flunixin held by manufacturers will be distributed alongside a ‘caution in use’ letter that will explain the restricted use of this product. BEVA is reminding all equine vets that the horse’s food chain status must be checked when using this product – either using the paper passport or the recently launched chip checker on the central equine database website.
The Mayor of Loughton, Councillor Philip Abraham, officially opened the Vets4Pets Loughton veterinary surgery inside Pets at Home at the Epping Forest Shopping Park, before enjoying a guided tour of the bright and modern facility.
Cheryl, who stars in the BBC’s children’s TV show The Pet Factor, said: "It’s fantastic to be able to open the doors to Vets4Pets Loughton and reach a landmark number of practices for the group.
"The opening event gave us chance to meet new clients, and welcome them to the practice."
Cheryl qualified in 2009 and is also a joint venture partner at Vets4Pets Chadwell and Newbury Park in Ilford.
Nick, who qualified in 2008, is also joint venture partner at Newbury Park, Romford, Beckton and Dagenham.
Nick said: "I have always been interested in caring for pets and have several dogs and cats at home.
"I love being a veterinary nurse and I’m delighted to have another opportunity from Vets4Pets to open my fifth practice.
"Once again the process to open a practice has been easy and we’ve had brilliant support on all aspects from Vets4Pets.
"I’m now looking forward to welcoming pets and their owners to Vets4Pets Loughton and providing the highest standard of veterinary care to the area’s pets."
The new practice will create five new jobs, with two vets, veterinary nurse, two pet care assistants and a receptionist.
Chief executive of the Pets at Home Vet Group, Andrei Balta, said: "Cheryl and Nick are two great advocates for the veterinary profession and we’re delighted they are part of the group.
"Wherever we have opened, pet owners have responded enthusiastically to our state-of-the-art practices and convenient opening hours.
"The joint venture model we operate across our practices provides the support vets and vet nurses need to run their businesses.
"It allows them to focus on what they really love, looking after the health of animals, while the support team helps with other areas including marketing, HR and business strategy."
The winning images were selected from nine finalists, shortlisted from hundreds of entries that were taken by vets, both in their professional and private lives.
And the winners are ...
Sophie said: “I was very surprised to win with my photo of a newborn calf standing next to me during the closing phases of surgery.
"I'm not that slow at suturing up, it’s just the calf was very alert and standing before I finished!
"For me this photo encapsulates the best parts of farm vetting: prompt decisions, safe handling, great outcomes, teamwork.
"I’m very proud to be a farm vet and exceptionally pleased this photo will be seen by current farm vets and hopefully will inspire future farm vets from all walks of life to pursue a veterinary career.”
Katherine, who is a third year Veterinary Medicine student at the Royal Veterinary College, said: “I'm absolutely delighted to have my photograph selected as the winner of the category, especially against such impressive entries.
"I was on a morning visit to a game reserve with a local vet in South Africa, when the sunrise highlighted the small oxpeckers on the backs of the giraffes, frantically flying to and fro.
"With the giraffe curiously watching us, I managed to capture the moment all three birds landed on its back, creating the image representing all creatures great and small.”
Sam Price said: "I took the image of my dog, Winnie, while on a campervan trip on the north coast of Ireland.
She loves nothing more than a beach day as you can see so I felt this was a fitting photo for the brief.
Thankfully there was a rare bout of sunshine on the day which made for some nice lighting and Winnie is pretty photogenic, which always helps!"
BVA President Malcolm Morley said: “The winning images stood out to us for many reasons, but we particularly liked how each one captured the essence of the category it was entered into; Sophie’s image of a c-section on a cow was so touching and really demonstrates the daily life of many of our valued farm vets; Katherine Edmondson’s photograph of the giraffe and red-billed oxpeckers was stunning but also truly embodied the All creatures great and small element; while Sam Price’s photo of Winnie the dog literally jumping for joy stole our hearts and genuinely made us all break out in smiles.
“Congratulations to all the winners, and also a huge well done to all the finalists as well, it was a really tough decision but you should be proud of the incredible photographs you entered and your talents.”
The new drug represents the fruit of 8 years of product development and more than 11 proprietary studies performed by Ceva R&D teams.
Marie Boutot, development project leader said: "Isemid is an original drug developed by Ceva, and was the subject of full pivotal efficacy and safety studies."
Ceva says the new drug has been recognised by the European Medicines Agency as a "2018 Innovation, advancing animal health".
Isemid is presented as pork-flavoured, scored tablets in three strengths: 1, 2 and 4 mg. They can be administered orally once daily, with or without food. The company's research showed a 98% owner compliance (compared to 92% for furosemide, p<0.05) and 80% voluntary acceptance.
Emilie Guillot, DVM, Ceva Technical Manager for Cardiology said: "With Isemid, we seek to help veterinarians in their goal to improve survival of dogs with heart failure.
"But above all, thanks to its potent action and long half-life which allow once-daily dosing, we hope to ease owner compliance."
Scientific communications with data on Isemid were presented at the American College of Veterinary Internal Medicine forum in Phoenix in June and will be held at the European College of Veterinary Internal Medicine congress in Milan in September.
Abbott Animal Health has announced the launch PropoFlo Plus, a 28-day preserved version of propofol intravenous anaesthetic for use in dogs and cats.
PropoFlo Plus contains benzyl alcohol, an antimicrobial preservative that provides it with a shelf life of 28 days, once opened. PropoFlo Plus is indicated for therapeutic use as a short-acting, intravenous general anaesthetic with a short recovery period. PropoFlo Plus can be used for procedures of a short duration, lasting up to approximately five minutes, and for induction of general anaesthesia where maintenance is provided by inhalation anaesthetic agents. Abbott says the extended shelf life of PropoFlo Plus provides an option for practices that may not routinely use an entire bottle of unpreserved propofol.
Jeff Schaffnit, Senior Director of Global Sales, Marketing and Business Development, Abbott Animal Health said: "Many veterinary surgeons are rightfully concerned about ways to save on costs and reduce waste in their practices, including anaesthetic waste. PropoFlo Plus is designed to minimise waste while providing veterinary surgeons with the confidence of using a familiar, trusted anaesthetic."
Abbott says that in addition to an extended shelf life, PropoFlo Plus provides the same established performance of PropoFlo, including:
The company also claims that studies show administering PropoFlo Plus results in no pain on injection.
PropoFlo Plus is available now through veterinary wholesalers. Abbott says it will be providing expert product support for PropoFlo Plus through local representatives, anaesthesia consultants and training tools for staff.
Idexx says the new test is proven to identify kidney disease earlier than creatinine1–3, enabling veterinary surgeons to intervene earlier and have a greater impact on patients' health outcomes and quality of life.
The Catalyst SDMA Test was first launched at the company's reference laboratories in 2015, since when Idexx says it has run more than 14 million SDMA patient tests, creating the world's largest database on kidney disease in dogs and cats.
The test was then launched to veterinary practices in the USA and Canada last December, where Idexx says it has now been used by thousands of practices.
Jonathan Ayers, Chairman and Chief Executive Officer of Idexx Laboratories said: "We've seen great enthusiasm for the ability to run SDMA as part of the routine chemistry panel at the point of care, and the North American launch has exceeded our expectations.
"The Idexx SDMA Test represents one of the most significant diagnostic innovations in veterinary medicine in the last 30 years. We're thrilled to bring this essential element of the chemistry panel to our point of care Idexx VetLab suite, allowing veterinarians to utilize the benefits of SDMA immediately during the pet's appointment."
Idexx has also signed an agreement to collaborate with Yale University to explore the test's applications in human health. As a result of the partnership, the SDMA Test has been validated for accuracy in measuring SDMA in human blood samples and the results presented at the 2017 annual meeting of the American Society of Nephrology last November by Yale and IDEXX researchers.
Jonathan added: "SDMA has tremendous potential benefit in human applications as well. And with the Idexx test technology now validated to be able to run on commercial chemistry systems that routinely produce chemistry results in human reference laboratories, we have greater reason to explore the clinical value of this incredible biomarker in human applications. We are excited and grateful for our partnership with Yale University."
Idexx says SDMA is now the subject of more than 30 ongoing research collaborations and has been incorporated into the veterinary profession's International Renal Interest Society (IRIS) kidney disease staging guidelines.
For more information about the IDEXX Catalyst SDMA Test, visit www.idexx.eu/sdma.
References
Prior to the start of the hearing, the RCVS received correspondence from Mr Kombert confirming that he did not intend to attend the hearing, either in person or via a video-link, nor did he intend to send legal representation in his stead.
The Committee, chaired by Dr Martin Whiting, decided to proceed with the hearing in the absence of Mr Kombert and any legal representation, on the basis that it was in the public interest and the interests of justice to proceed and that Mr Kombert had been given the opportunity to attend or be represented.
The Committee heard that staff at the practice where Mr Kombert was working as a locum had undertaken a check of the medicines kept in the practice’s controlled drugs cabinet and discovered that 5.5ml of ketamine and 1.5ml of methadone was missing. After the code to the controlled drugs cabinet was changed, Mr Kombert was observed taking an additional 3ml of methadone, which he then administered to himself while on duty at the practice.
After Mr Kombert was confronted with the evidence, he was given the details of the Vetlife charity for support and asked not to return to the practice.
The police were contacted and, on 4 January 2019, Mr Kombert was arrested and interviewed. He received a police caution for theft, with conditions that he should attend and complete a drug-use awareness course, and engage in a restorative justice process, which involved attending the practice to discuss his offences. At this meeting, Mr Kombert admitted stealing the drugs and administering them to himself while on duty, which meant he was not in a fit state to see patients. He apologised for his actions and the matter was then also reported to the RCVS.
In relation to the fact that Mr Kombert had accepted the police caution, made the admissions at the restorative justice meeting and had emailed the RCVS apologising for his actions, the facts of the case were found proven.
The Committee then went on to consider if Mr Kombert’s actions amounted to disgraceful conduct in a professional respect (henceforth called ‘serious professional misconduct’), something which Mr Kombert had admitted to in correspondence with the RCVS.
The Committee found that Mr Kombert’s actions did amount to serious professional misconduct. Dr Martin Whiting, chairing the Committee and speaking on its behalf, said: "The respondent’s conduct was dishonest; it constituted both a breach of trust and an abuse of his position with regards to access to veterinary medicines; it risked animal welfare and jeopardised the reputation of colleagues. It fell far short of the conduct expected of a member of the profession and amounts to disgraceful conduct in a professional respect."
The Committee then considered what the appropriate sanction against Mr Kombert should be, taking into account both aggravating and mitigating factors.
In terms of aggravating factors, the Committee took into account the risk of harm to animals, his dishonesty, the premeditated nature of the misconduct, the breach of trust and the fact it was repeated.
It also took into account three previous matters recorded against Mr Kombert in the United States of America.
These were: a letter of admonition from the Colorado State Board of Veterinary Medicine for practising when his licence had expired; a stipulation order from the same body in which he agreed to relinquish his licence in that state following an allegation that he took controlled substances from a veterinary practice and self-administered them; and a criminal conviction in New York State for obtaining an opioid controlled drug by deception, for which he was sentenced to three years’ probation. The Committee was made aware of the New York State criminal conviction after Dianne Norris, a Probation Officer based in that state, had contacted the RCVS after hearing about the inquiry and informed the College that Mr Kombert was in breach of his probation conditions.
Dr Whiting said: “The Committee has considered the witness statement of Ms Dianne Norris, a probation officer employed by Putnam County Probation in New York, who was responsible for supervising the respondent as part of his probation. Ms Norris explained that the respondent breached his probation on numerous occasions, which took place from November 2017 to 2018…. As a result of the breaches, Ms Norris required the respondent to increase his attendance at support groups to an inpatient treatment program for 28 days from 13 July 2018. He failed to attend.
"Ms Norris explained that warrants were issued for the respondent’s arrest…. The Committee noted that the conduct of the respondent in relation to obtaining controlled drugs from his employers for his own use while in the United States of America was similar to his conduct … [described in] the charges."
In mitigation the Committee considered that Mr Kombert had consistently admitted the charges against him as well as accepting and agreeing with the evidence against him.
However, the Committee decided that in light of the seriousness of his misconduct, including dishonesty and risk of serious harm to animals, removal from the Register was the most appropriate and proportionate sanction.
Summing up, Dr Whiting said: "The respondent has failed to uphold the requisite standards to be expected of him on multiple occasions. The Committee considers that the only sanction that is sufficient to protect the welfare of animals, maintain public confidence in the profession and declare and uphold proper standards of conduct is one of erasure."
Mr Kombert has 28 days from being informed of the outcome of the hearing in which to make an appeal to the Privy Council.
The full facts and findings from the case can be found at www.rcvs.org.uk/disciplinary
Staffies were by far the most commonly stolen animal, accounting for 25.7% of all reported dogs thefts in the UK between 2017 and 2021.
Meanwhile, Devon and Cornwall had the highest number of pet thefts: 140.6 per 100,000 people.
Northumbria came second, with 61.5 pet thefts per 100,000 people, and Lancashire third (52.9 per 100,000).
On the other end of the scale, one breed that was less likely to be stolen was the pug (4.5%), although that's perhaps not surprising: after all, who'd want to steal an animal whose face you can't differentiate from its backside?
The safest animal in the country is probably an Akita (1.9%) living in Surrey (6.8 pet thefts per 100,000 people).
Full report: https://www.adt.co.uk/blog/the-adt-pet-theft-report
The company says the product is highly effective against common bacteria including Staphylococci, Clostridia, Corynebacteria and Streptococci, and gram-negative bacteria including Bacteroides spp, Pasteurellae, and Proteus spp.
Clavubactin is available in a range of dose strengths to treat all sizes of patient. It is presented as a doubly divisible tablet for accurate and flexible dosing and to help avoid the development of antibiotic resistance associated with under dosing. The tablets come in blister packs of 10, designed to help reduce unnecessary exposure when dispensing in practice.
Dechra Brand Manager Carol Morgan said: "The introduction of Clavubactin to our antibiotic portfolio will give veterinary professionals even more choice of effective and targeted treatments in their day-to-day practice."